Stryker Corporation

New York Stock Exchange
Somewhat Bearish -25

Fisher Asset Management LLC Trims Position in Stryker Corporation $SYK - MarketBeat

📉 Fisher Asset Management trimmed its Stryker position by 5.8% in Q4, selling 192,839 shares while retaining a $1.10 billion stake.

💰 Stryker reported Q4 EPS of $2.60 and revenue of $6.02 billion, missing analyst estimates for both metrics despite positive YoY revenue growth.

📊 Analyst consensus has weakened with UBS, TD Cowen, and Goldman Sachs issuing neutral or hold ratings following the earnings miss.

🏦 Major institutional investors like Vanguard and AllianceBernstein increased their stakes, indicating continued long-term confidence.

💸 VP M Kathryn Fink sold 95.19% of her shares for $992,075 in a May transaction, signaling insider caution.

📈 The stock trades at a PE ratio of 36.62 with a market cap of $121.29 billion and a current price near $316.

💵 Stryker declared a quarterly dividend of $0.88 per share, offering a yield of 1.1% to eligible investors.

🔮 The company provided FY 2026 EPS guidance ranging between $14.90 and $15.10.

Bullish Signals
  • Vanguard Group Inc. increased its stake in Stryker by 0.4% to own over 33.9 million shares, demonstrating strong institutional confidence.
  • Alliancebernstein L.P. significantly raised its position by 13.3% in the third quarter, adding over 741,000 shares to its portfolio.
  • Stryker achieved a 2.6% year-over-year revenue increase to $6.02 billion, showing underlying business growth despite missing earnings estimates.
  • The company maintains healthy financial metrics with a current ratio of 2.11 and a debt-to-equity ratio of only 0.62.
  • Stryker declared a quarterly dividend of $0.88 per share, providing a 1.1% yield to shareholders of record on June 30th.
Risk Factors
  • Stryker missed analyst expectations for both EPS ($2.60 vs $2.98) and revenue ($6.02B vs $6.34B) in the most recent quarter.
  • Several major analysts have downgraded the stock or lowered price targets, including UBS cutting its target to $380 with a neutral rating.
  • VP M Kathryn Fink sold 95.19% of her personal holdings for nearly $1 million, indicating significant insider selling activity.
  • The stock is trading below its 50-day ($325.22) and 200-day ($349.76) moving averages, suggesting short-term weakness.
Full Analysis
Fisher Asset Management LLC reduced its stake in Stryker Corporation (NYSE: SYK) by 5.8% during the fourth quarter, selling 192,839 shares and retaining a position valued at approximately $1.10 billion. This move coincides with Stryker's recent quarterly earnings miss, where the company reported EPS of $2.60 against expectations of $2.98 and revenue of $6.02 billion versus an estimated $6.34 billion, despite a 2.6% year-over-year revenue increase. Analyst sentiment has shifted toward caution following the earnings miss, with several major firms lowering price targets or downgrading ratings. UBS cut its target to $380 with a neutral rating, while TD Cowen and Goldman Sachs also issued neutral or hold ratings. Despite these headwinds, the stock maintains a 'Moderate Buy' consensus with an average price target of $395.48, though recent downgrades suggest growing skepticism among Wall Street analysts. Institutional ownership remains robust, with Vanguard increasing its stake by 0.4% and AllianceBernstein raising theirs by 13.3%. However, insider activity presents a mixed signal; while major funds are accumulating, Stryker VP M Kathryn Fink sold 95.19% of her holdings for nearly $1 million in May. The company also declared a quarterly dividend of $0.88 per share, payable on July 31st to shareholders of record on June 30th.